Bg pattern

OFTALMOLOSA CUSI HYDROCORTISONE 15 mg/g OPHTHALMIC OINTMENT

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use OFTALMOLOSA CUSI HYDROCORTISONE 15 mg/g OPHTHALMIC OINTMENT

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

OFTALMOLOSA CUSÍ HYDROCORTISONE 15 mg/g Ophthalmic Ointment

Hydrocortisone Acetate

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the Package Leaflet

  1. What OFTALMOLOSA CUSÍ HYDROCORTISONE is and what it is used for
  2. What you need to know before you use OFTALMOLOSA CUSÍ HYDROCORTISONE
  3. How to use OFTALMOLOSA CUSÍ HYDROCORTISONE
  4. Possible side effects

5 Storage of OFTALMOLOSA CUSÍ HYDROCORTISONE

  1. Contents of the pack and other information

1. What OFTALMOLOSA CUSÍ HYDROCORTISONE is and what it is used for

It is an ophthalmic ointment (for the eyes) that contains hydrocortisone as the active ingredient, a corticosteroid used in the treatment of certain inflammatory eye disorders.

OFTALMOLOSA CUSÍ HYDROCORTISONE is indicated for the treatment of non-infectious allergic or allergic-inflammatory processes of the anterior segment of the eye, eyelid eczema, blepharitis (inflammation of the eyelid), iritis (inflammation of the iris or colored part of the eye), cyclitis (inflammation of the ciliary body), or iridocyclitis (inflammation of the iris and ciliary body).

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use OFTALMOLOSA CUSÍ HYDROCORTISONE

Do not use OFTALMOLOSA CUSÍ HYDROCORTISONE:

  • If you are allergic to hydrocortisone or any of the other ingredients of this medicine (listed in section 6).
  • If you have or think you have:
  • Untreated bacterial eye infections.
  • Herpes simplex keratitis (inflammation of the cornea caused by the herpes simplex virus) or any other viral eye infection, such as smallpox or chickenpox.
  • Fungal eye diseases.
  • Tuberculosis that affects the eye.
  • Simple glaucoma.

Warnings and Precautions

Consult your doctor or pharmacist before starting to use OFTALMOLOSA CUSÍ HYDROCORTISONE.

  • Only use this medicine in your eye(s).
  • If you use this medicine for a long time, you may:
  • Develop increased eye pressure and/or glaucoma (with damage to the optic nerve and decreased visual acuity). You should regularly check your eye pressure while using this medicine. Consult your doctor if you have any doubts. The risk of increased intraocular pressure and/or cataract formation induced by corticosteroids is higher in children and prone patients (e.g., diabetes and myopia).
  • Develop cataracts. You should visit your doctor frequently.
  • If your symptoms worsen or come back, consult your doctor. You may become more sensitive to eye infections with the use of this medicine. Corticosteroids can also mask the signs of an infection or worsen it, especially with prolonged use in purulent eye infections.
  • If you already have a bacterial eye infection, you should consult your doctor about your treatment.
  • Prolonged use of corticosteroids in the eyes could produce fungal corneal infections. If this occurs, treatment should be discontinued. The use of corticosteroids in the eye in excessive doses can delay the healing of eye wounds. It is also known that ophthalmic non-steroidal anti-inflammatory drugs (NSAIDs) slow down or delay healing (see "Other medicines and OFTALMOLOSA CUSÍ HYDROCORTISONE").
  • If you have a disorder that causes thinning of the ocular tissue (the outermost layers of the eye), the use of this medicine could cause corneal perforation.
  • Contact your doctor if you experience blurred vision or other visual disturbances.

If you wear contact lenses

Wearing contact lenses (hard or soft) is not recommended during the treatment of an eye inflammation.

Children

The safety and efficacy of this medicine in children have not been established. Therefore, its use is not recommended in children.

Other medicines and OFTALMOLOSA CUSÍ HYDROCORTISONE

Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.

Tell your doctor if you are using ophthalmic NSAIDs. The combined use of corticosteroids and ophthalmic NSAIDs can increase corneal healing problems.

Some medicines may increase the effects of OFTALMOLOSA CUSÍ HYDROCORTISONE, so your doctor will monitor you closely if you are taking these medicines (including some for HIV: ritonavir, cobicistat).

Pregnancy, Breastfeeding, and Fertility

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.

The use of OFTALMOLOSA CUSÍ HYDROCORTISONE is not recommended during pregnancy.

If you are breastfeeding, your doctor should decide whether to discontinue breastfeeding or discontinue treatment with this medicine, taking into account the benefit of breastfeeding for the child and the benefit of treatment for the mother.

Driving and Using Machines

You may notice that your vision becomes blurred for a while after applying the ointment. Do not drive or use machines until these effects have disappeared.

OFTALMOLOSA CUSÍ HYDROCORTISONE contains lanolin and butylhydroxytoluene (BHT)

This medicine may cause local skin reactions (such as contact dermatitis) because it contains lanolin and butylhydroxytoluene. This medicine may cause eye and mucous membrane irritation because it contains butylhydroxytoluene.

3. How to use OFTALMOLOSA CUSÍ HYDROCORTISONE

Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. If you are in doubt, consult your doctor or pharmacist again.

Ophthalmic route (in the eye/eyes).

The recommended dose is:

Adults:

Apply approximately 1 cm of ointment two or three times a day to the affected eye(s).

It is not recommended to use this product for more than 14 days, unless otherwise indicated by your doctor.

Recommendations for use:

  • Take the tube.
  • Stand in front of a mirror and wash your hands.
  • If the application is inside the eye, separate the lower eyelid with a clean finger. Apply the ointment to the pouch that forms between the eyelid and the eye while looking up.
  • If the application is outside the eye, apply the ointment directly to the affected area, first softening any crusts with warm water.
  • Place the tip of the tube close to the eye. Use a mirror if needed.
  • Do not touch the eye(s), eyelids, surrounding areas, or other surfaces with the tip of the tube to prevent eye infections.
  • Gently press the tube to release the ointment.
  • Close the eye(s) for a few seconds after applying the ointment.
  • Close the tube tightly after use.

If you are using other ophthalmic medicines, wait at least 5 minutes between the administration of this medicine and the other medicines. Ophthalmic ointments should be administered last.

If you use more OFTALMOLOSA CUSÍ HYDROCORTISONE than you should

An overdose in the eyes can be eliminated by rinsing the eyes with lukewarm water.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount used.

If you forget to use OFTALMOLOSA CUSÍ HYDROCORTISONE

Do not apply a double dose to make up for forgotten doses.

Apply a single dose as soon as you remember and continue with the next scheduled dose. If it is almost time for the next dose, do not apply the missed dose and continue with your regular dosing schedule.

If you have any further questions about the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The following side effects have been reported with this medicine. The frequency cannot be estimated from the available data:

  • Eye effects: blurred vision

Prolonged use of corticosteroids in the eyes can also cause:

  • Increased eye pressure and/or glaucoma with damage to the optic nerve and decreased visual acuity.
  • Cataract formation.
  • Delayed healing of the cornea.
  • In diseases that cause thinning of the cornea, there is a higher risk of perforation.

Corticosteroids can reduce resistance to eye infections, favoring their appearance.

Additionally, the following side effects have been observed with the use of ophthalmic corticosteroids in general:

  • Eye effects: transient burning sensation, eyelid edema (fluid retention), eyelid erythema (redness), anterior uveitis (inflammation of the uvea), cycloplegia (paralysis of the ciliary muscle), mydriasis (pupil dilation), ptosis (drooping eyelid), thinning of the sclera (white of the eye) after prolonged use, and keratitis (inflammation of the cornea).
  • General effects: hypersensitivity (allergy), rare cases of Cushing's syndrome (swelling and weight gain of the body and face) and local skin reactions such as allergic contact dermatitis, redness, and irritation.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaRAM.es.By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of OFTALMOLOSA CUSÍ HYDROCORTISONE

Keep this medicine out of the sight and reach of children.

Do not store above 25°C.

To avoid infections, the tube should be discarded 4 weeks after the first opening.

Write the date of opening of the tube in the space provided for this purpose on the carton.

Do not use this medicine after the expiry date which is stated on the packaging after EXP. The expiry date is the last day of the month shown.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and other information

Composition of OFTALMOLOSA CUSÍ HYDROCORTISONE

  • The active ingredient is hydrocortisone acetate. Each gram of ointment contains 15 mg of hydrocortisone acetate (1.5%).
  • The other ingredients are: lanolin (contains butylhydroxytoluene), liquid paraffin, and white petrolatum.

Appearance of the product and contents of the pack

OFTALMOLOSA CUSÍ HYDROCORTISONE is a yellowish ophthalmic ointment.

It is available in aluminum tubes with a polyethylene cap containing 3 g of ointment.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder

OmniVision GmbH

Lindberghstrasse 9

82178 Puchheim

Germany

Manufacturer

Siegfried El Masnou, S.A.

C/ Camil Fabra, 58

08320 El Masnou – Barcelona, Spain

Local Representative

OmniVision Farma España S.L.

C/ Josep Irla i Bosch, 1-3

Pl: 6 Pt: 2

08034 Barcelona

Spain

Date of the last revision of this leaflet:September 2024

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for OFTALMOLOSA CUSI HYDROCORTISONE 15 mg/g OPHTHALMIC OINTMENT

Discuss questions about OFTALMOLOSA CUSI HYDROCORTISONE 15 mg/g OPHTHALMIC OINTMENT, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for OFTALMOLOSA CUSI HYDROCORTISONE 15 mg/g OPHTHALMIC OINTMENT?
OFTALMOLOSA CUSI HYDROCORTISONE 15 mg/g OPHTHALMIC OINTMENT requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in OFTALMOLOSA CUSI HYDROCORTISONE 15 mg/g OPHTHALMIC OINTMENT?
The active ingredient in OFTALMOLOSA CUSI HYDROCORTISONE 15 mg/g OPHTHALMIC OINTMENT is hydrocortisone. This information helps identify medicines with the same composition but different brand names.
How much does OFTALMOLOSA CUSI HYDROCORTISONE 15 mg/g OPHTHALMIC OINTMENT cost in pharmacies?
The average pharmacy price for OFTALMOLOSA CUSI HYDROCORTISONE 15 mg/g OPHTHALMIC OINTMENT is around 3.36 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures OFTALMOLOSA CUSI HYDROCORTISONE 15 mg/g OPHTHALMIC OINTMENT?
OFTALMOLOSA CUSI HYDROCORTISONE 15 mg/g OPHTHALMIC OINTMENT is manufactured by Omnivision Gmbh. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of OFTALMOLOSA CUSI HYDROCORTISONE 15 mg/g OPHTHALMIC OINTMENT online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether OFTALMOLOSA CUSI HYDROCORTISONE 15 mg/g OPHTHALMIC OINTMENT is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to OFTALMOLOSA CUSI HYDROCORTISONE 15 mg/g OPHTHALMIC OINTMENT?
Other medicines with the same active substance (hydrocortisone) include SOFTACORT 3.35 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS, AMEXXINE 1 mg/ml EYE DROPS SOLUTION, COLIRCUSI DEXAMETHASONE 1 mg/ml eye drops solution. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media